Information received by medtronic indicated that the customer experienced a hypoglycemia and had glucose/carb intake as treatment.Customer blood glucose level was around 52 mg/dl.Customer also received unexpected battery power loss, insulin flow block and failed in displacement test.It was unknown about used insulin pump system within 48 hours of reported event.It was unknown about troubleshooting was performed and used the minimed 670g/770g/780g system with the auto mode/smartguard feature actively at time of low blood glucose event.Customer was also advised the insulin, reservoir, and infusion set will be replaced.Pump was not expected to be returned for analysis.Frn-unk-rsvr, unomed inf set.
|
(b)(4).Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.No conclusion can be drawn at this time.We therefore consider this report complete to the best of our knowledge.The insulin pump involved in this event is the ngp 640g insulin pump which is not marketed in the united states.However, the device is similar to the ngp insulin pump, which is marketed in the united states.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|